These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8443983)

  • 1. Cell surface expression of lysosome-associated membrane proteins (LAMPs) in scleroderma: relationship of lamp2 to disease duration, anti-Sc170 antibodies, serum interleukin-8, and soluble interleukin-2 receptor levels.
    Holcombe RF; Baethge BA; Stewart RM; Betzing K; Hall VC; Fukuda M; Wolf RE
    Clin Immunol Immunopathol; 1993 Apr; 67(1):31-9. PubMed ID: 8443983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus.
    Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM; Hall VC; Fukuda M
    Lupus; 1994 Apr; 3(2):97-102. PubMed ID: 7920621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium.
    Kannan K; Stewart RM; Bounds W; Carlsson SR; Fukuda M; Betzing KW; Holcombe RF
    Cell Immunol; 1996 Jul; 171(1):10-9. PubMed ID: 8660832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface expression of lysosome-associated membrane protein-2 (lamp2) and CD63 as markers of in vivo platelet activation in malignancy.
    Kannan K; Divers SG; Lurie AA; Chervenak R; Fukuda M; Holcombe RF
    Eur J Haematol; 1995 Sep; 55(3):145-51. PubMed ID: 7672086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cells and gamma delta T cells in scleroderma: relationship to disease duration and anti-Scl-70 antibodies.
    Holcombe RF; Baethge BA; Wolf RE; Betzing KW; Stewart RM
    Ann Rheum Dis; 1995 Jan; 54(1):69-72. PubMed ID: 7533490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Danon disease: a focus on processing of the novel LAMP2 mutation and comments on the beneficial use of peripheral white blood cells in the diagnosis of LAMP2 deficiency.
    Majer F; Vlaskova H; Krol L; Kalina T; Kubanek M; Stolnaya L; Dvorakova L; Elleder M; Sikora J
    Gene; 2012 May; 498(2):183-95. PubMed ID: 22365987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysosomal membrane glycoproteins bind cholesterol and contribute to lysosomal cholesterol export.
    Li J; Pfeffer SR
    Elife; 2016 Sep; 5():. PubMed ID: 27664420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chediak-Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins.
    Jones KL; Stewart RM; Fowler M; Fukuda M; Holcombe RF
    Clin Immunol Immunopathol; 1992 Dec; 65(3):219-26. PubMed ID: 1333377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis.
    Hasegawa M; Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
    J Rheumatol; 1998 Feb; 25(2):308-13. PubMed ID: 9489824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
    Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
    J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.
    Ihn H; Fujimoto M; Sato S; Kikuchi K; Igarashi A; Soma Y; Takehara K
    J Am Acad Dermatol; 1994 Oct; 31(4):591-5. PubMed ID: 7916356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Arch Dermatol Res; 1995; 287(2):193-7. PubMed ID: 7763091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone upregulates LAMP2 expression and lysosome activity.
    Tseng YH; Chang CC; Lin KH
    Biochem Biophys Res Commun; 2023 Jun; 662():66-75. PubMed ID: 37099812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells.
    Grützkau A; Smorodchenko A; Lippert U; Kirchhof L; Artuc M; Henz BM
    Cytometry A; 2004 Sep; 61(1):62-8. PubMed ID: 15351990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of the immune response to type I collagen in scleroderma.
    Warrington KJ; Nair U; Carbone LD; Kang AH; Postlethwaite AE
    Arthritis Res Ther; 2006; 8(4):R136. PubMed ID: 16879746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infection of epithelial cells by pathogenic neisseriae reduces the levels of multiple lysosomal constituents.
    Ayala P; Lin L; Hopper S; Fukuda M; So M
    Infect Immun; 1998 Oct; 66(10):5001-7. PubMed ID: 9746610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LAMPs: Shedding light on cancer biology.
    Alessandrini F; Pezzè L; Ciribilli Y
    Semin Oncol; 2017 Aug; 44(4):239-253. PubMed ID: 29526252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells.
    Sarafian V; Jadot M; Foidart JM; Letesson JJ; Van den Brûle F; Castronovo V; Wattiaux R; Coninck SW
    Int J Cancer; 1998 Jan; 75(1):105-11. PubMed ID: 9426697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
    York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
    Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.